News

  • Longitudinal proteomic profiling of high-risk patients with COVID-19

    Background/design End-stage kidney disease (ESKD) patients are at high risk of severe COVID-19, and in this study, longitudinal protein profiling with five different Olink® Target 96 panels was used to measure 436 circulating proteins in 55 hospitalized/non-hospitalized ESKD patients with COVID-19, ...
  • SCALLOP publication in Nature Metabolism

    A study of cardiovascular proteins in over 30 000 individuals A major proteogenomic study from SCALLOP identifies >450 pQTLs and several novel potential drug targets   Illustration by Ann-Louise Bergström (Moving Science ApS) In an important new study published in Nature...
  • Plasma ACE2 and risk of death or cardiometabolic diseases

    Large epidemiological study of association of plasma ACE2 levels with CVD risk Cardiovascular diseases have been one of the most studied comorbidities in connection with COVID-19. A study by researchers at Hamilton Health Sciences in Ontario, Canada has examined the levels of the S...
  • Update of our Target 96 Development panel (Oct 2020)

    In response to customer feedback and as part of Olink’s commitment to improve and develop our offering, a change has been made to the Olink®Target 96 Development panel. A high performance assay with a possible role in bone remodeling, metabolic diseases and tumorigenesis has been selected from...
  • MGH/Olink collaboration to investigate the plasma proteomic signatures of COVID-19 positive patients

    Olink Explore 1536 accelerates COVID-19 research and the identification of new biomarkers Olink is immensely proud of our contribution to one of the largest longitudinal COVID-19 studies to date, together with the prestigious Massachusetts General Hospital (MGH). In close collaboration with the team...
  • Multisystem Inflammatory Syndrome in Children with COVID-19

    Insights into a rare but severe complication in children with COVID-19 A study by Petter Brodin’s group at the Karolinska Institiute has looked into an aspect of the COVID-19 pandemic that has perhaps not received enough attention to date. While the large majority of children ...
  • Immune response in mild versus severe COVID-19 infections

    New insights into immune responses in severe COVID-19 A study by researchers at Stanford University and other institutions reveals how the immune system goes awry leading to severe disease during SARS-CoV-2 infections,  and may point to novel therapeutic targets. Taking a systems bi...
  • Olink Proteomics and WuXi NextCODE announce strategic cooperation

    July 8, 2020 With this new and important collaboration, customers in China will have access to run Olink fee for service projects in a similar way that customers have in other parts of the world. It will also mean that WuXi NextCODE will further improve their capability for high-thr...
  • Systems-level immunomonitoring of severe COVID-19

    June 9, 2020 A study by Petter Brodin’s group at the Karolinska Institute in Stockholm has used a longitudinal, systems-level approach to characterize immune responses at both the cellular and protein level in severe COVID-19, and during the transition from acute disease to th...
  • Free Olink statistical analysis app available

    June 4, 2020 Olink has developed a new online app for statistical analysis of NPX data. Olink® Insights Stat Analysis  is a web-based tool for basic data visualizations and statistical analyses, and is based on the same tools and methods as are used by the Olink Dat...